Besides, GSEA enrichment analysis demonstrated that low-risk group patients exhibit significantly enriched pathways such as the ERBB signaling pathway, MAPK signaling pathway, pathways of cancer, renal cell carcinoma, TCG beta signaling pathway, and WNT signaling pathway. This evidence concerns the gene EGFR and cancer.